Matt Kaeberlein: The Peptide Risk Scale (You Won’t Believe Who’s Safe)

🟢
Peer-Reviewed Research
M
Matt Kaeberlein

Video Summary · February 28, 2026

View Full Protocol →

Key Takeaways

  • Compounding pharmacies/distributors face highest legal risk (FDA warnings, seizures, license loss, DOJ prosecution)
  • Clinicians/physicians risk medical board action or malpractice suits if prescribing illegal peptides
  • Patients have minimal legal risk but assume health risks from unapproved peptides

Notable Quotes

“Patients in general have little to no legal responsibility. It’s not saying there’s no risk, just not legal risk.”

Bottom Line

Avoid illegal peptides – while patients face low legal consequences, providers and pharmacies risk severe penalties, and unapproved substances endanger health.

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts